Skip to main content
. 2021 Oct;10(10):4062–4074. doi: 10.21037/tau-20-938

Table 5. Pairwise comparisons of overall survival grouped according to risk assessment by MSKCC-score and physician.

Risk-attribution Both g Phys g MSKCC i Phys g MSKCC p Phys i MSKCC g both i Phys i MSKCC p Phys p MSKCC g Phys p MSKCC i Both p
Both g 0.40 0.14 0.32 0.11 0.25 0.26 0.20 0.12
Phys g MSKCC i 0.40 0.04 0.83 0.09 0.39 0.17 0.11 <0.01
Phys g MSKCC p 0.14 0.04 0.07 0.10 0.73 0.40 0.41 0.64
Phys i MSKCC g 0.32 0.83 0.07 0.29 0.31 0.16 0.26 0.09
Both i 0.11 0.09 0.10 0.29 0.68 0.34 0.29 <0.01
Phys i MSKCC p 0.25 0.39 0.73 0.31 0.68 0.59 0.86 0.09
Phys p MSKCC g 0.26 0.17 0.40 0.16 0.34 0.59 0.79 0.85
Phys p MSKCC i 0.20 0.11 0.41 0.26 0.29 0.86 0.79 <0.01
Both p 0.12 <0.01 0.64 0.09 <0.01 0.09 0.85 <0.01

MSKCC, Memorial Sloan-Kettering Cancer Center prognostic score; g, good; i, intermediate; p, poor; n-p, non-poor.